TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Prescription Dermatological Drugs Market Insights and Forecast to 2028

Global Prescription Dermatological Drugs Market Insights and Forecast to 2028

  • Category:Life Sciences
  • Published on : 28 July 2022
  • Pages :107
  • Formats:
  • Report Code:SMR-7240089
OfferClick for best price

Best Price: $3920

Prescription Dermatological Drugs Market Size, Share 2022


Market Analysis and Insights: Global Prescription Dermatological Drugs Market

The global Prescription Dermatological Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Prescription Dermatological Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Prescription Dermatological Drugs market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Prescription Dermatological Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Prescription Dermatological Drugs market.

Global Prescription Dermatological Drugs Scope and Market Size

Prescription Dermatological Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Prescription Dermatological Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Anti-acne Drugs

Anti-aging Drugs

Dermatitis Drugs

Hair Loss Drugs

Psoriasis Drugs

Skin Cancer Drugs

Melasma Drugs

Seborrhea Drugs

Segment by Application

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Company

Johnson & Johnson

Merck

LEO Pharma

Mylan Pharmaceuticals

Pfizer

Roche

Allergan

Bausch Health

PharmaDerm Pharmaceuticals

Allergan Inamed Corporation

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Prescription Dermatological Drugs product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Prescription Dermatological Drugs, with price, sales, revenue, and global market share of Prescription Dermatological Drugs from 2019 to 2022.

Chapter 3, the Prescription Dermatological Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Prescription Dermatological Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Prescription Dermatological Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Prescription Dermatological Drugs.

Chapter 13, 14, and 15, to describe Prescription Dermatological Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Prescription Dermatological Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Prescription Dermatological Drugs Market Insights and Forecast to 2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 107 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Study Coverage
1.1 Prescription Dermatological Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Prescription Dermatological Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Anti-acne Drugs
1.2.3 Anti-aging Drugs
1.2.4 Dermatitis Drugs
1.2.5 Hair Loss Drugs
1.2.6 Psoriasis Drugs
1.2.7 Skin Cancer Drugs
1.2.8 Melasma Drugs
1.2.9 Seborrhea Drugs
1.3 Market by Application
1.3.1 Global Prescription Dermatological Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Prescription Dermatological Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Prescription Dermatological Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Prescription Dermatological Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Prescription Dermatological Drugs Sales by Region
2.4.1 Global Prescription Dermatological Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Prescription Dermatological Drugs by Region (2023-2028)
2.5 Global Prescription Dermatological Drugs Revenue by Region
2.5.1 Global Prescription Dermatological Drugs Revenue by Region (2017-2022)
2.5.2 Global Prescription Dermatological Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Prescription Dermatological Drugs Sales by Manufacturers
3.1.1 Global Top Prescription Dermatological Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Prescription Dermatological Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Prescription Dermatological Drugs in 2021
3.2 Global Prescription Dermatological Drugs Revenue by Manufacturers
3.2.1 Global Prescription Dermatological Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Prescription Dermatological Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Prescription Dermatological Drugs Revenue in 2021
3.3 Global Prescription Dermatological Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Prescription Dermatological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Prescription Dermatological Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Prescription Dermatological Drugs Sales by Type
4.1.1 Global Prescription Dermatological Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Prescription Dermatological Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Prescription Dermatological Drugs Sales Market Share by Type (2017-2028)
4.2 Global Prescription Dermatological Drugs Revenue by Type
4.2.1 Global Prescription Dermatological Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Prescription Dermatological Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Prescription Dermatological Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Prescription Dermatological Drugs Price by Type
4.3.1 Global Prescription Dermatological Drugs Price by Type (2017-2022)
4.3.2 Global Prescription Dermatological Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Prescription Dermatological Drugs Sales by Application
5.1.1 Global Prescription Dermatological Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Prescription Dermatological Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Prescription Dermatological Drugs Sales Market Share by Application (2017-2028)
5.2 Global Prescription Dermatological Drugs Revenue by Application
5.2.1 Global Prescription Dermatological Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Prescription Dermatological Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Prescription Dermatological Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Prescription Dermatological Drugs Price by Application
5.3.1 Global Prescription Dermatological Drugs Price by Application (2017-2022)
5.3.2 Global Prescription Dermatological Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Prescription Dermatological Drugs Market Size by Type
6.1.1 North America Prescription Dermatological Drugs Sales by Type (2017-2028)
6.1.2 North America Prescription Dermatological Drugs Revenue by Type (2017-2028)
6.2 North America Prescription Dermatological Drugs Market Size by Application
6.2.1 North America Prescription Dermatological Drugs Sales by Application (2017-2028)
6.2.2 North America Prescription Dermatological Drugs Revenue by Application (2017-2028)
6.3 North America Prescription Dermatological Drugs Market Size by Country
6.3.1 North America Prescription Dermatological Drugs Sales by Country (2017-2028)
6.3.2 North America Prescription Dermatological Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Prescription Dermatological Drugs Market Size by Type
7.1.1 Europe Prescription Dermatological Drugs Sales by Type (2017-2028)
7.1.2 Europe Prescription Dermatological Drugs Revenue by Type (2017-2028)
7.2 Europe Prescription Dermatological Drugs Market Size by Application
7.2.1 Europe Prescription Dermatological Drugs Sales by Application (2017-2028)
7.2.2 Europe Prescription Dermatological Drugs Revenue by Application (2017-2028)
7.3 Europe Prescription Dermatological Drugs Market Size by Country
7.3.1 Europe Prescription Dermatological Drugs Sales by Country (2017-2028)
7.3.2 Europe Prescription Dermatological Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Prescription Dermatological Drugs Market Size by Type
8.1.1 Asia Pacific Prescription Dermatological Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Prescription Dermatological Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Prescription Dermatological Drugs Market Size by Application
8.2.1 Asia Pacific Prescription Dermatological Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Prescription Dermatological Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Prescription Dermatological Drugs Market Size by Region
8.3.1 Asia Pacific Prescription Dermatological Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Prescription Dermatological Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Prescription Dermatological Drugs Market Size by Type
9.1.1 Latin America Prescription Dermatological Drugs Sales by Type (2017-2028)
9.1.2 Latin America Prescription Dermatological Drugs Revenue by Type (2017-2028)
9.2 Latin America Prescription Dermatological Drugs Market Size by Application
9.2.1 Latin America Prescription Dermatological Drugs Sales by Application (2017-2028)
9.2.2 Latin America Prescription Dermatological Drugs Revenue by Application (2017-2028)
9.3 Latin America Prescription Dermatological Drugs Market Size by Country
9.3.1 Latin America Prescription Dermatological Drugs Sales by Country (2017-2028)
9.3.2 Latin America Prescription Dermatological Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Prescription Dermatological Drugs Market Size by Type
10.1.1 Middle East and Africa Prescription Dermatological Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Prescription Dermatological Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Prescription Dermatological Drugs Market Size by Application
10.2.1 Middle East and Africa Prescription Dermatological Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Prescription Dermatological Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Prescription Dermatological Drugs Market Size by Country
10.3.1 Middle East and Africa Prescription Dermatological Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Prescription Dermatological Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Corporation Information
11.1.2 Johnson & Johnson Overview
11.1.3 Johnson & Johnson Prescription Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Johnson & Johnson Prescription Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Johnson & Johnson Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Prescription Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Merck Prescription Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Recent Developments
11.3 LEO Pharma
11.3.1 LEO Pharma Corporation Information
11.3.2 LEO Pharma Overview
11.3.3 LEO Pharma Prescription Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 LEO Pharma Prescription Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 LEO Pharma Recent Developments
11.4 Mylan Pharmaceuticals
11.4.1 Mylan Pharmaceuticals Corporation Information
11.4.2 Mylan Pharmaceuticals Overview
11.4.3 Mylan Pharmaceuticals Prescription Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Mylan Pharmaceuticals Prescription Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Mylan Pharmaceuticals Recent Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Prescription Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Pfizer Prescription Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Recent Developments
11.6 Roche
11.6.1 Roche Corporation Information
11.6.2 Roche Overview
11.6.3 Roche Prescription Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Roche Prescription Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Roche Recent Developments
11.7 Allergan
11.7.1 Allergan Corporation Information
11.7.2 Allergan Overview
11.7.3 Allergan Prescription Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Allergan Prescription Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Allergan Recent Developments
11.8 Bausch Health
11.8.1 Bausch Health Corporation Information
11.8.2 Bausch Health Overview
11.8.3 Bausch Health Prescription Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Bausch Health Prescription Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bausch Health Recent Developments
11.9 PharmaDerm Pharmaceuticals
11.9.1 PharmaDerm Pharmaceuticals Corporation Information
11.9.2 PharmaDerm Pharmaceuticals Overview
11.9.3 PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 PharmaDerm Pharmaceuticals Recent Developments
11.10 Allergan Inamed Corporation
11.10.1 Allergan Inamed Corporation Corporation Information
11.10.2 Allergan Inamed Corporation Overview
11.10.3 Allergan Inamed Corporation Prescription Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Allergan Inamed Corporation Prescription Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Allergan Inamed Corporation Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Prescription Dermatological Drugs Industry Chain Analysis
12.2 Prescription Dermatological Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Prescription Dermatological Drugs Production Mode & Process
12.4 Prescription Dermatological Drugs Sales and Marketing
12.4.1 Prescription Dermatological Drugs Sales Channels
12.4.2 Prescription Dermatological Drugs Distributors
12.5 Prescription Dermatological Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Prescription Dermatological Drugs Industry Trends
13.2 Prescription Dermatological Drugs Market Drivers
13.3 Prescription Dermatological Drugs Market Challenges
13.4 Prescription Dermatological Drugs Market Restraints
14 Key Findings in The Global Prescription Dermatological Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Prescription Dermatological Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Anti-acne Drugs
Table 3. Major Manufacturers of Anti-aging Drugs
Table 4. Major Manufacturers of Dermatitis Drugs
Table 5. Major Manufacturers of Hair Loss Drugs
Table 6. Major Manufacturers of Psoriasis Drugs
Table 7. Major Manufacturers of Skin Cancer Drugs
Table 8. Major Manufacturers of Melasma Drugs
Table 9. Major Manufacturers of Seborrhea Drugs
Table 10. Global Prescription Dermatological Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Prescription Dermatological Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 12. Global Prescription Dermatological Drugs Sales by Region (2017-2022) & (K Units)
Table 13. Global Prescription Dermatological Drugs Sales Market Share by Region (2017-2022)
Table 14. Global Prescription Dermatological Drugs Sales by Region (2023-2028) & (K Units)
Table 15. Global Prescription Dermatological Drugs Sales Market Share by Region (2023-2028)
Table 16. Global Prescription Dermatological Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 17. Global Prescription Dermatological Drugs Revenue Market Share by Region (2017-2022)
Table 18. Global Prescription Dermatological Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 19. Global Prescription Dermatological Drugs Revenue Market Share by Region (2023-2028)
Table 20. Global Prescription Dermatological Drugs Sales by Manufacturers (2017-2022) & (K Units)
Table 21. Global Prescription Dermatological Drugs Sales Share by Manufacturers (2017-2022)
Table 22. Global Prescription Dermatological Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 23. Global Prescription Dermatological Drugs Revenue Share by Manufacturers (2017-2022)
Table 24. Prescription Dermatological Drugs Price by Manufacturers (2017-2022) &(USD/Units)
Table 25. Global Prescription Dermatological Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Prescription Dermatological Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Dermatological Drugs as of 2021)
Table 27. Prescription Dermatological Drugs Manufacturing Base Distribution and Headquarters
Table 28. Manufacturers Prescription Dermatological Drugs Product Offered
Table 29. Date of Manufacturers Enter into Prescription Dermatological Drugs Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Prescription Dermatological Drugs Sales by Type (2017-2022) & (K Units)
Table 32. Global Prescription Dermatological Drugs Sales by Type (2023-2028) & (K Units)
Table 33. Global Prescription Dermatological Drugs Sales Share by Type (2017-2022)
Table 34. Global Prescription Dermatological Drugs Sales Share by Type (2023-2028)
Table 35. Global Prescription Dermatological Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 36. Global Prescription Dermatological Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 37. Global Prescription Dermatological Drugs Revenue Share by Type (2017-2022)
Table 38. Global Prescription Dermatological Drugs Revenue Share by Type (2023-2028)
Table 39. Prescription Dermatological Drugs Price by Type (2017-2022) & (USD/Units)
Table 40. Global Prescription Dermatological Drugs Price Forecast by Type (2023-2028) & (USD/Units)
Table 41. Global Prescription Dermatological Drugs Sales by Application (2017-2022) & (K Units)
Table 42. Global Prescription Dermatological Drugs Sales by Application (2023-2028) & (K Units)
Table 43. Global Prescription Dermatological Drugs Sales Share by Application (2017-2022)
Table 44. Global Prescription Dermatological Drugs Sales Share by Application (2023-2028)
Table 45. Global Prescription Dermatological Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 46. Global Prescription Dermatological Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 47. Global Prescription Dermatological Drugs Revenue Share by Application (2017-2022)
Table 48. Global Prescription Dermatological Drugs Revenue Share by Application (2023-2028)
Table 49. Prescription Dermatological Drugs Price by Application (2017-2022) & (USD/Units)
Table 50. Global Prescription Dermatological Drugs Price Forecast by Application (2023-2028) & (USD/Units)
Table 51. North America Prescription Dermatological Drugs Sales by Type (2017-2022) & (K Units)
Table 52. North America Prescription Dermatological Drugs Sales by Type (2023-2028) & (K Units)
Table 53. North America Prescription Dermatological Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 54. North America Prescription Dermatological Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 55. North America Prescription Dermatological Drugs Sales by Application (2017-2022) & (K Units)
Table 56. North America Prescription Dermatological Drugs Sales by Application (2023-2028) & (K Units)
Table 57. North America Prescription Dermatological Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 58. North America Prescription Dermatological Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 59. North America Prescription Dermatological Drugs Sales by Country (2017-2022) & (K Units)
Table 60. North America Prescription Dermatological Drugs Sales by Country (2023-2028) & (K Units)
Table 61. North America Prescription Dermatological Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 62. North America Prescription Dermatological Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 63. Europe Prescription Dermatological Drugs Sales by Type (2017-2022) & (K Units)
Table 64. Europe Prescription Dermatological Drugs Sales by Type (2023-2028) & (K Units)
Table 65. Europe Prescription Dermatological Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 66. Europe Prescription Dermatological Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 67. Europe Prescription Dermatological Drugs Sales by Application (2017-2022) & (K Units)
Table 68. Europe Prescription Dermatological Drugs Sales by Application (2023-2028) & (K Units)
Table 69. Europe Prescription Dermatological Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 70. Europe Prescription Dermatological Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 71. Europe Prescription Dermatological Drugs Sales by Country (2017-2022) & (K Units)
Table 72. Europe Prescription Dermatological Drugs Sales by Country (2023-2028) & (K Units)
Table 73. Europe Prescription Dermatological Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 74. Europe Prescription Dermatological Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 75. Asia Pacific Prescription Dermatological Drugs Sales by Type (2017-2022) & (K Units)
Table 76. Asia Pacific Prescription Dermatological Drugs Sales by Type (2023-2028) & (K Units)
Table 77. Asia Pacific Prescription Dermatological Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 78. Asia Pacific Prescription Dermatological Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 79. Asia Pacific Prescription Dermatological Drugs Sales by Application (2017-2022) & (K Units)
Table 80. Asia Pacific Prescription Dermatological Drugs Sales by Application (2023-2028) & (K Units)
Table 81. Asia Pacific Prescription Dermatological Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 82. Asia Pacific Prescription Dermatological Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 83. Asia Pacific Prescription Dermatological Drugs Sales by Region (2017-2022) & (K Units)
Table 84. Asia Pacific Prescription Dermatological Drugs Sales by Region (2023-2028) & (K Units)
Table 85. Asia Pacific Prescription Dermatological Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 86. Asia Pacific Prescription Dermatological Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 87. Latin America Prescription Dermatological Drugs Sales by Type (2017-2022) & (K Units)
Table 88. Latin America Prescription Dermatological Drugs Sales by Type (2023-2028) & (K Units)
Table 89. Latin America Prescription Dermatological Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 90. Latin America Prescription Dermatological Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 91. Latin America Prescription Dermatological Drugs Sales by Application (2017-2022) & (K Units)
Table 92. Latin America Prescription Dermatological Drugs Sales by Application (2023-2028) & (K Units)
Table 93. Latin America Prescription Dermatological Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 94. Latin America Prescription Dermatological Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 95. Latin America Prescription Dermatological Drugs Sales by Country (2017-2022) & (K Units)
Table 96. Latin America Prescription Dermatological Drugs Sales by Country (2023-2028) & (K Units)
Table 97. Latin America Prescription Dermatological Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 98. Latin America Prescription Dermatological Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Prescription Dermatological Drugs Sales by Type (2017-2022) & (K Units)
Table 100. Middle East and Africa Prescription Dermatological Drugs Sales by Type (2023-2028) & (K Units)
Table 101. Middle East and Africa Prescription Dermatological Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Prescription Dermatological Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Prescription Dermatological Drugs Sales by Application (2017-2022) & (K Units)
Table 104. Middle East and Africa Prescription Dermatological Drugs Sales by Application (2023-2028) & (K Units)
Table 105. Middle East and Africa Prescription Dermatological Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Prescription Dermatological Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 107. Middle East and Africa Prescription Dermatological Drugs Sales by Country (2017-2022) & (K Units)
Table 108. Middle East and Africa Prescription Dermatological Drugs Sales by Country (2023-2028) & (K Units)
Table 109. Middle East and Africa Prescription Dermatological Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 110. Middle East and Africa Prescription Dermatological Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 111. Johnson & Johnson Corporation Information
Table 112. Johnson & Johnson Description and Major Businesses
Table 113. Johnson & Johnson Prescription Dermatological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2017-2022)
Table 114. Johnson & Johnson Prescription Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Johnson & Johnson Recent Developments
Table 116. Merck Corporation Information
Table 117. Merck Description and Major Businesses
Table 118. Merck Prescription Dermatological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2017-2022)
Table 119. Merck Prescription Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Merck Recent Developments
Table 121. LEO Pharma Corporation Information
Table 122. LEO Pharma Description and Major Businesses
Table 123. LEO Pharma Prescription Dermatological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2017-2022)
Table 124. LEO Pharma Prescription Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. LEO Pharma Recent Developments
Table 126. Mylan Pharmaceuticals Corporation Information
Table 127. Mylan Pharmaceuticals Description and Major Businesses
Table 128. Mylan Pharmaceuticals Prescription Dermatological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2017-2022)
Table 129. Mylan Pharmaceuticals Prescription Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Mylan Pharmaceuticals Recent Developments
Table 131. Pfizer Corporation Information
Table 132. Pfizer Description and Major Businesses
Table 133. Pfizer Prescription Dermatological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2017-2022)
Table 134. Pfizer Prescription Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Pfizer Recent Developments
Table 136. Roche Corporation Information
Table 137. Roche Description and Major Businesses
Table 138. Roche Prescription Dermatological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2017-2022)
Table 139. Roche Prescription Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Roche Recent Developments
Table 141. Allergan Corporation Information
Table 142. Allergan Description and Major Businesses
Table 143. Allergan Prescription Dermatological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2017-2022)
Table 144. Allergan Prescription Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Allergan Recent Developments
Table 146. Bausch Health Corporation Information
Table 147. Bausch Health Description and Major Businesses
Table 148. Bausch Health Prescription Dermatological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2017-2022)
Table 149. Bausch Health Prescription Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Bausch Health Recent Developments
Table 151. PharmaDerm Pharmaceuticals Corporation Information
Table 152. PharmaDerm Pharmaceuticals Description and Major Businesses
Table 153. PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2017-2022)
Table 154. PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. PharmaDerm Pharmaceuticals Recent Developments
Table 156. Allergan Inamed Corporation Corporation Information
Table 157. Allergan Inamed Corporation Description and Major Businesses
Table 158. Allergan Inamed Corporation Prescription Dermatological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2017-2022)
Table 159. Allergan Inamed Corporation Prescription Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. Allergan Inamed Corporation Recent Developments
Table 161. Key Raw Materials Lists
Table 162. Raw Materials Key Suppliers Lists
Table 163. Prescription Dermatological Drugs Distributors List
Table 164. Prescription Dermatological Drugs Customers List
Table 165. Prescription Dermatological Drugs Market Trends
Table 166. Prescription Dermatological Drugs Market Drivers
Table 167. Prescription Dermatological Drugs Market Challenges
Table 168. Prescription Dermatological Drugs Market Restraints
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Prescription Dermatological Drugs Product Picture
Figure 3. Global Prescription Dermatological Drugs Market Share by Type in 2021 & 2028
Figure 3. Anti-acne Drugs Product Picture
Figure 4. Anti-aging Drugs Product Picture
Figure 5. Dermatitis Drugs Product Picture
Figure 6. Hair Loss Drugs Product Picture
Figure 7. Psoriasis Drugs Product Picture
Figure 8. Skin Cancer Drugs Product Picture
Figure 9. Melasma Drugs Product Picture
Figure 10. Seborrhea Drugs Product Picture
Figure 11. Global Prescription Dermatological Drugs Market Share by Application in 2021 & 2028
Figure 12. Hospital Pharmacies
Figure 13. Retail Pharmacies
Figure 14. Online Pharmacies
Figure 15. Prescription Dermatological Drugs Report Years Considered
Figure 16. Global Prescription Dermatological Drugs Sales 2017-2028 (K Units)
Figure 17. Global Prescription Dermatological Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 18. Global Prescription Dermatological Drugs Revenue 2017-2028 (US$ Million)
Figure 19. Global Prescription Dermatological Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 20. Global Prescription Dermatological Drugs Sales Market Share by Region (2017-2022)
Figure 21. Global Prescription Dermatological Drugs Sales Market Share by Region (2023-2028)
Figure 22. North America Prescription Dermatological Drugs Sales YoY (2017-2028) & (K Units)
Figure 23. North America Prescription Dermatological Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Europe Prescription Dermatological Drugs Sales YoY (2017-2028) & (K Units)
Figure 25. Europe Prescription Dermatological Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Asia-Pacific Prescription Dermatological Drugs Sales YoY (2017-2028) & (K Units)
Figure 27. Asia-Pacific Prescription Dermatological Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Latin America Prescription Dermatological Drugs Sales YoY (2017-2028) & (K Units)
Figure 29. Latin America Prescription Dermatological Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Middle East & Africa Prescription Dermatological Drugs Sales YoY (2017-2028) & (K Units)
Figure 31. Middle East & Africa Prescription Dermatological Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 32. The Prescription Dermatological Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 33. The Top 5 and 10 Largest Manufacturers of Prescription Dermatological Drugs in the World: Market Share by Prescription Dermatological Drugs Revenue in 2021
Figure 34. Global Prescription Dermatological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 35. Global Prescription Dermatological Drugs Sales Market Share by Type (2017-2028)
Figure 36. Global Prescription Dermatological Drugs Revenue Market Share by Type (2017-2028)
Figure 37. Global Prescription Dermatological Drugs Sales Market Share by Application (2017-2028)
Figure 38. Global Prescription Dermatological Drugs Revenue Market Share by Application (2017-2028)
Figure 39. North America Prescription Dermatological Drugs Sales Market Share by Type (2017-2028)
Figure 40. North America Prescription Dermatological Drugs Revenue Market Share by Type (2017-2028)
Figure 41. North America Prescription Dermatological Drugs Sales Market Share by Application (2017-2028)
Figure 42. North America Prescription Dermatological Drugs Revenue Market Share by Application (2017-2028)
Figure 43. North America Prescription Dermatological Drugs Sales Share by Country (2017-2028)
Figure 44. North America Prescription Dermatological Drugs Revenue Share by Country (2017-2028)
Figure 45. U.S. Prescription Dermatological Drugs Revenue (2017-2028) & (US$ Million)
Figure 46. Canada Prescription Dermatological Drugs Revenue (2017-2028) & (US$ Million)
Figure 47. Europe Prescription Dermatological Drugs Sales Market Share by Type (2017-2028)
Figure 48. Europe Prescription Dermatological Drugs Revenue Market Share by Type (2017-2028)
Figure 49. Europe Prescription Dermatological Drugs Sales Market Share by Application (2017-2028)
Figure 50. Europe Prescription Dermatological Drugs Revenue Market Share by Application (2017-2028)
Figure 51. Europe Prescription Dermatological Drugs Sales Share by Country (2017-2028)
Figure 52. Europe Prescription Dermatological Drugs Revenue Share by Country (2017-2028)
Figure 53. Germany Prescription Dermatological Drugs Revenue (2017-2028) & (US$ Million)
Figure 54. France Prescription Dermatological Drugs Revenue (2017-2028) & (US$ Million)
Figure 55. U.K. Prescription Dermatological Drugs Revenue (2017-2028) & (US$ Million)
Figure 56. Italy Prescription Dermatological Drugs Revenue (2017-2028) & (US$ Million)
Figure 57. Russia Prescription Dermatological Drugs Revenue (2017-2028) & (US$ Million)
Figure 58. Asia Pacific Prescription Dermatological Drugs Sales Market Share by Type (2017-2028)
Figure 59. Asia Pacific Prescription Dermatological Drugs Revenue Market Share by Type (2017-2028)
Figure 60. Asia Pacific Prescription Dermatological Drugs Sales Market Share by Application (2017-2028)
Figure 61. Asia Pacific Prescription Dermatological Drugs Revenue Market Share by Application (2017-2028)
Figure 62. Asia Pacific Prescription Dermatological Drugs Sales Share by Region (2017-2028)
Figure 63. Asia Pacific Prescription Dermatological Drugs Revenue Share by Region (2017-2028)
Figure 64. China Prescription Dermatological Drugs Revenue (2017-2028) & (US$ Million)
Figure 65. Japan Prescription Dermatological Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. South Korea Prescription Dermatological Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. India Prescription Dermatological Drugs Revenue (2017-2028) & (US$ Million)
Figure 68. Australia Prescription Dermatological Drugs Revenue (2017-2028) & (US$ Million)
Figure 69. Taiwan Prescription Dermatological Drugs Revenue (2017-2028) & (US$ Million)
Figure 70. Indonesia Prescription Dermatological Drugs Revenue (2017-2028) & (US$ Million)
Figure 71. Thailand Prescription Dermatological Drugs Revenue (2017-2028) & (US$ Million)
Figure 72. Malaysia Prescription Dermatological Drugs Revenue (2017-2028) & (US$ Million)
Figure 73. Philippines Prescription Dermatological Drugs Revenue (2017-2028) & (US$ Million)
Figure 74. Latin America Prescription Dermatological Drugs Sales Market Share by Type (2017-2028)
Figure 75. Latin America Prescription Dermatological Drugs Revenue Market Share by Type (2017-2028)
Figure 76. Latin America Prescription Dermatological Drugs Sales Market Share by Application (2017-2028)
Figure 77. Latin America Prescription Dermatological Drugs Revenue Market Share by Application (2017-2028)
Figure 78. Latin America Prescription Dermatological Drugs Sales Share by Country (2017-2028)
Figure 79. Latin America Prescription Dermatological Drugs Revenue Share by Country (2017-2028)
Figure 80. Mexico Prescription Dermatological Drugs Revenue (2017-2028) & (US$ Million)
Figure 81. Brazil Prescription Dermatological Drugs Revenue (2017-2028) & (US$ Million)
Figure 82. Argentina Prescription Dermatological Drugs Revenue (2017-2028) & (US$ Million)
Figure 83. Middle East and Africa Prescription Dermatological Drugs Sales Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Prescription Dermatological Drugs Revenue Market Share by Type (2017-2028)
Figure 85. Middle East and Africa Prescription Dermatological Drugs Sales Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Prescription Dermatological Drugs Revenue Market Share by Application (2017-2028)
Figure 87. Middle East and Africa Prescription Dermatological Drugs Sales Share by Country (2017-2028)
Figure 88. Middle East and Africa Prescription Dermatological Drugs Revenue Share by Country (2017-2028)
Figure 89. Turkey Prescription Dermatological Drugs Revenue (2017-2028) & (US$ Million)
Figure 90. Saudi Arabia Prescription Dermatological Drugs Revenue (2017-2028) & (US$ Million)
Figure 91. U.A.E Prescription Dermatological Drugs Revenue (2017-2028) & (US$ Million)
Figure 92. Prescription Dermatological Drugs Value Chain
Figure 93. Prescription Dermatological Drugs Production Process
Figure 94. Channels of Distribution
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount